Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease – Cardiovascular Diabetology – Cardiovascular Diabetology

Sun H, et al. Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article PubMed Google Scholar

Standards of medical care in diabetes2014 Diabetes Care, 2014. 37 Suppl 1: pp. S14-80.

Nichols GA, et al. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24(9):16149.

Article CAS PubMed Google Scholar

Dei Cas A, et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015;3(2):13645.

Article PubMed Google Scholar

Harding JL, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):316.

Article PubMed Google Scholar

Dasari D, et al. Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function. Eur J Pharmacol. 2023;949:175720.

Article CAS PubMed Google Scholar

Fang P, et al. Glucagon-like peptide-1receptor agonist protects against diabetic cardiomyopathy by modulating microRNA-29b-3p/SLMAP. Drug Des Devel Ther. 2023;17:791806.

Article CAS PubMed PubMed Central Google Scholar

Yang Z, et al. Metformin ameliorates diabetic cardiomyopathy by activating the PK2/PKR pathway. Front Physiol. 2020;11:425.

Article PubMed PubMed Central Google Scholar

Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):150125.

CAS Google Scholar

Phang RJ, et al. Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy. Cardiovasc Res. 2023;119(3):66890.

Article CAS PubMed Google Scholar

Prakoso D, et al. Current landscape of preclinical models of diabetic cardiomyopathy. Trends Pharmacol Sci. 2022;43(11):94056.

Article CAS PubMed Google Scholar

Astorri E, et al. Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment. Cardiology. 1997;88(2):1525.

Article CAS PubMed Google Scholar

Yamada T, et al. Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018;20(7):175561.

Article CAS PubMed Google Scholar

Mathieu C, et al. Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE Treat-To-Target Randomized Trial. Diabetes Care. 2016;39(10):170210.

Article CAS PubMed Google Scholar

Marx N et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043140.

Park MD, et al. Macrophages in health and disease. Cell. 2022;185(23):425979.

Article CAS PubMed PubMed Central Google Scholar

Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):78795.

Article CAS PubMed PubMed Central Google Scholar

Wculek SK, et al. Metabolism of tissue macrophages in homeostasis and pathology. Cell Mol Immunol. 2022;19(3):384408.

Article CAS PubMed Google Scholar

Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal. 2011;11:2391402.

Article CAS PubMed PubMed Central Google Scholar

Bashir S, et al. Macrophage polarization: the link between inflammation and related diseases. Inflamm Res. 2016;65(1):111.

Article CAS PubMed Google Scholar

Peng C, Li Z, Yu X. The role of pancreatic infiltrating innate immune cells in acute pancreatitis. Int J Med Sci. 2021;18(2):53445.

Article CAS PubMed PubMed Central Google Scholar

Sterling KG et al. Mucosal immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease. Int J Mol Sci, 2022. 23(21).

Hu Z, et al. Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI-CKD transition. Ren Fail. 2023;45(1):2149412.

Article PubMed PubMed Central Google Scholar

Braga TT, Agudelo JS, Camara NO. Macrophages during the fibrotic process: M2 as friend and Foe. Front Immunol. 2015;6:602.

Article PubMed PubMed Central Google Scholar

Mills CD, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164(12):616673.

Article CAS PubMed Google Scholar

Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:12347.

Article CAS PubMed Google Scholar

Nahrendorf M, Swirski FK. Abandoning M1/M2 for a network model of macrophage function. Circ Res. 2016;119(3):4147.

Article CAS PubMed PubMed Central Google Scholar

Gosselin D, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014;159(6):132740.

Article CAS PubMed PubMed Central Google Scholar

Tan Y, et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585607.

Article PubMed PubMed Central Google Scholar

Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):62438.

Article CAS PubMed PubMed Central Google Scholar

Seferovi PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36(27):171827.

Article PubMed Google Scholar

Marwick TH, et al. Implications of underlying mechanisms for the Recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2018;71(3):33951.

Article PubMed Google Scholar

Lin HT et al. (1)H nuclear magnetic resonance (NMR)-Based cerebrospinal fluid and plasma metabolomic analysis in type 2 Diabetic patients and Risk Prediction for Diabetic Microangiopathy. J Clin Med, 2019. 8(6).

DeBerge M, et al. Macrophages in Heart failure with reduced versus preserved ejection fraction. Trends Mol Med. 2019;25(4):32840.

Article PubMed PubMed Central Google Scholar

Jin X, et al. Advanced Glycation End products enhance macrophages polarization into M1 phenotype through activating RAGE/NF-B pathway. Biomed Res Int. 2015;2015:p732450.

Article Google Scholar

Mishra PK, et al. Diabetic Cardiomyopathy: an immunometabolic perspective. Front Endocrinol (Lausanne). 2017;8:72.

Article PubMed Google Scholar

Watanabe R et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight, 2018. 3(20).

Mouton AJ, et al. Obesity, hypertension, and Cardiac Dysfunction: Novel roles of Immunometabolism in Macrophage activation and inflammation. Circ Res. 2020;126(6):789806.

Article CAS PubMed PubMed Central Google Scholar

Dinh W, et al. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol. 2009;8:58.

Article PubMed PubMed Central Google Scholar

Masters SL, Latz E, ONeill LA. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med. 2011;3(81):81ps17.

Article PubMed Google Scholar

Biernacka A, et al. Smad3 Signaling promotes Fibrosis while preserving Cardiac and aortic geometry in obese Diabetic mice. Circ Heart Fail. 2015;8(4):78898.

Article CAS PubMed PubMed Central Google Scholar

Bajpai A, Tilley DG. The role of leukocytes in Diabetic Cardiomyopathy. Front Physiol. 2018;9:1547.

Article PubMed PubMed Central Google Scholar

Kokkola R, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 2005;61(1):19.

Article CAS PubMed Google Scholar

Volz HC, et al. The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost. 2010;36(2):18594.

Article CAS PubMed Google Scholar

Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):20622.

Article CAS PubMed Google Scholar

Frantz S, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999;104(3):27180.

Article CAS PubMed PubMed Central Google Scholar

Zhang Y, et al. Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of toll-like receptor-4. J Transl Med. 2010;8:133.

Article CAS PubMed PubMed Central Google Scholar

Dong B, et al. TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol. 2012;303(6):H73242.

Article CAS PubMed PubMed Central Google Scholar

Tao A, et al. Cardiomyocyte-fibroblast interaction contributes to diabetic cardiomyopathy in mice: role of HMGB1/TLR4/IL-33 axis. Biochim Biophys Acta. 2015;1852(10 Pt A):207585.

Article CAS PubMed Google Scholar

Wang Y, et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun. 2017;8:13997.

Article CAS PubMed PubMed Central Google Scholar

Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):29923002.

Article CAS PubMed PubMed Central Google Scholar

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):11119.

Article CAS PubMed PubMed Central Google Scholar

Aguirre V, et al. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of ser(307). J Biol Chem. 2000;275(12):904754.

Read the rest here:
Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease - Cardiovascular Diabetology - Cardiovascular Diabetology